Italy· 015148125
FARLUTAL*30 cpr 500 mg
A medicinal product containing medrossiprogesterone, registered in Italy by PFIZER ITALIA Srl, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Medrossiprogesterone
- Manufacturer
- PFIZER ITALIA Srl
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic015148125FARLUTAL*30 cpr 500 mgEUR 97.93
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Medrossiprogesterone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDepo-ProveraPharmacia & Upjohn Company LLC
- United KingdomAdgyn Medro 5mg tabletsKyowa Kirin Ltd
- FinlandCykrinaWyeth Medica Ireland
- BelgiumDepo-Provera 1000, 1000 mgPfizer
- CzechiaDEPO-PROVERAPfizer, spol. s r.o., Praha
- CanadaAA-MEDROXYAA PHARMA INC
- NetherlandsDepo-Provera 150, suspensie voor injectie 150 mg/mlPfizer B.V.
- Japanメドロキシプロゲステロン酢酸エステル協和キリン
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Depocon, Farlutal
- Belgium · Depo-Provera, Provera
- Bulgaria · Фарлутал
- Czechia · Depo-Provera, Provera
- Germany · Depo-Clinovir, Mpa
- Denmark · Depo-Provera, Provera
- Estonia · Farlutal
- Spain · Depo-Progevera, Progevera
- Finland · Farlutal, Provera
- France · Depo Prodasone, Depo Provera
- United Kingdom (Northern Ireland) · Depo-Provera, Medroxyprogesterone Acetate Pfizer
- Croatia · Provera
- Hungary · Depo-Provera, Provera
- Ireland · Depo-Provera, Provera
- Iceland · Depo-Provera
- Luxembourg · Depo-Provera, Provera
- Latvia · Depo-Provera
- Netherlands · Depo-Provera, Provera
- Norway · Depo-Provera, Provera
- Poland · Depo-Provera, Provera
- Portugal · Depo-Provera 150
- Sweden · Depo-Provera, Provera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5a07988-272c-40c6-a612-d41b1ab16bdd GET /v1/drugs/f5a07988-272c-40c6-a612-d41b1ab16bdd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 97.93,
"source": "aifa",
"currency": "EUR",
"strength": "MEDROSSIPROGESTERONE 500MG 30 UNITA' USO ORALE",
"substance": "Medrossiprogesterone",
"equivalence_group": "OCF",
"transparency_flag": null
}See everything about medrossiprogesterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.